Exploring Chronic Hypocalcemia: Insights into Autoimmune Polyglandular Syndrome Type 1-A Case Study and Literature

Giorgiana-Flavia Brad1,2, Delia-Maria Nicoară1, Alexandra-Cristina Scutca1,2

  • 1Department XI Pediatrics, Discipline I Pediatrics, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania.

PubMed

Insights

This study highlights a pediatric case of hypocalcemia caused by a rare autoimmune polyendocrine syndrome type 1 (APS-1), identified through genetic sequencing of the AIRE gene. Early diagnosis and management are crucial for this multisystemic condition.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Genetics
  • Immunology

Background:

  • Hypocalcemia is common in children, with varied causes and presentations.
  • Chronic hypocalcemia can stem from primary hypoparathyroidism.
  • Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare, multisystemic disorder often underdiagnosed due to varied manifestations.

Purpose of the Study:

  • To report a pediatric case of hypocalcemia due to APS-1.
  • To review the clinical, genetic, and immunological aspects of APS-1.
  • To emphasize the importance of AIRE gene mutations in APS-1 diagnosis and management.

Main Methods:

  • Case presentation of a 7-year-old male with hypocalcemia.
  • Targeted next-generation sequencing to identify genetic mutations.
  • Comprehensive literature review on APS-1.

Main Results:

  • A homozygous p.R257X mutation in the AIRE gene was identified, confirming APS-1.
  • The case illustrates the diagnostic challenges of APS-1.
  • Literature review provided insights into APS-1's clinical spectrum and immunological mechanisms.

Conclusions:

  • AIRE gene mutations are key for diagnosing APS-1.
  • Individualized management, monitoring, and early identification of associated conditions are vital for APS-1 patients.
  • Recognizing APS-1 is crucial for appropriate prognosis and treatment strategies.

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
87
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
86
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257